Verastem (VSTM) PT Raised to $14 at RBC Capital; 'Stock Is Oversold' Nov 5, 2025 10:03AM
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
Verastem Oncology to Present at Upcoming Investor Conferences May 1, 2025 07:30AM
Verastem Oncology (VSTM) Prices $75M Share Offering at $7/sh Apr 25, 2025 09:00AM
Verastem Oncology Announces $75 million Private Placement Apr 25, 2025 09:00AM


Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
May 28, 2024 06:27AM Verastem (VSTM) PT Lowered to $16 at RBC Capital
May 7, 2024 07:30AM Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Jun 16, 2023 05:54AM Verastem Oncology (VSTM) Prices 7.18M Share and Warrant Offering at $9.75/sh
Jun 16, 2023 05:00AM Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Jun 15, 2023 04:00PM Verastem Oncology (VSTM) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jun 15, 2023 04:00PM Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
May 1, 2023 07:00AM Verastem Oncology to Participate in Upcoming Investor Conferences
Apr 14, 2022 04:01AM UPDATE: RBC Capital Starts Verastem (VSTM) at Outperform
May 16, 2018 09:20AM Pre-Open Movers 05/16: (BOOT) (ABAX) (M) Higher; (VSTM) (SRAX) (ABR) Lower (more...)
Jul 29, 2013 10:35AM Notable Analyst Rating Changes 07/29: (TTM) (DHI) (WCRX) Upgraded; (MSFT) (TROW) (RVBD) Downgraded